Infectivity of deceased COVID-19 patients.


Journal

International journal of legal medicine
ISSN: 1437-1596
Titre abrégé: Int J Legal Med
Pays: Germany
ID NLM: 9101456

Informations de publication

Date de publication:
Sep 2021
Historique:
received: 09 11 2020
accepted: 15 02 2021
pubmed: 6 3 2021
medline: 19 8 2021
entrez: 5 3 2021
Statut: ppublish

Résumé

The duration of infectivity of SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) in living patients has been demarcated. In contrast, a possible SARS-CoV-2 infectivity of corpses and subsequently its duration under post mortem circumstances remain to be elucidated. The aim of this study was to investigate the infectivity and its duration of deceased COVID-19 (coronavirus disease) patients. Four SARS-CoV-2 infected deceased patients were subjected to medicolegal autopsy. Post mortem intervals (PMI) of 1, 4, 9 and 17 days, respectively, were documented. During autopsy, swabs and organ samples were taken and examined by RT-qPCR (real-time reverse transcription-polymerase chain reaction) for the detection of SARS-CoV-2 ribonucleic acid (RNA). Determination of infectivity was performed by means of virus isolation in cell culture. In two cases, virus isolation was successful for swabs and tissue samples of the respiratory tract (PMI 4 and 17 days). The two infectious cases showed a shorter duration of COVID-19 until death than the two non-infectious cases (2 and 11 days, respectively, compared to > 19 days), which correlates with studies of living patients, in which infectivity could be narrowed to about 6 days before to 12 days after symptom onset. Most notably, infectivity was still present in one of the COVID-19 corpses after a post-mortem interval of 17 days and despite already visible signs of decomposition. To prevent SARS-CoV-2 infections in all professional groups involved in the handling and examination of COVID-19 corpses, adequate personal safety standards (reducing or avoiding aerosol formation and wearing FFP3 [filtering face piece class 3] masks) have to be enforced for routine procedures.

Identifiants

pubmed: 33665704
doi: 10.1007/s00414-021-02546-7
pii: 10.1007/s00414-021-02546-7
pmc: PMC7932833
doi:

Substances chimiques

RNA, Viral 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2055-2060

Informations de copyright

© 2021. The Author(s).

Références

World Health Organization (2020) Novel coronavirus (2019-nCoV) situation reports. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports . Accessed 30 Apr 2020
Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR (2020) Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges. Int J Antimicrob Agents 55(3):105924
doi: 10.1016/j.ijantimicag.2020.105924
Wichmann D, Sperhake JP, Lütgehetmann M, Steurer S, Edler C, Heinemann A, Heinrich F, Mushumba H, Kniep I, Schröder AS, Burdelski C, de Heer G, Nierhaus A, Frings D, Pfefferle S, Becker H, Bredereke-Wiedling H, de Weerth A, Paschen HR, Sheikhzadeh-Eggers S, Stang A, Schmiedel S, Bokemeyer C, Addo MM, Aepfelbacher M, Püschel K, Kluge S (2020) Autopsy findings and venous thromboembolism in patients with COVID-19: a prospective cohort study. Ann Intern Med 173(4):268–277
doi: 10.7326/M20-2003
Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, Mehra MR, Schuepbach RA, Ruschitzka F, Moch H (2020) Endothelial cell infection and endotheliitis in COVID-19. Lancet 395(10234):1417–1418
doi: 10.1016/S0140-6736(20)30937-5
Edler C, Schröder AS, Aepfelbacher M, Fitzek A, Heinemann A, Heinrich F, Klein A, Langenwalder F, Lütgehetmann M, Meißner K, Püschel K, Schädler J, Steurer S, Mushumba H, Sperhake JP (2020) Dying with SARS-CoV-2 infection-an autopsy study of the first consecutive 80 cases in Hamburg, Germany. Int J Legal Med 134(4):1275–1284
doi: 10.1007/s00414-020-02317-w
Sriwijitalai W, Wiwanitkit V (2020) COVID-19 in forensic medicine unit personnel: observation from Thailand. J Forensic Legal Med 72:101964
doi: 10.1016/j.jflm.2020.101964
Sriwijitalai W, Wiwanitkit V (2020) Corrigendum to “COVID-19 in forensic medicine unit personnel: observation from Thailand”. J Forensic Legal Med 72:101967
doi: 10.1016/j.jflm.2020.101967
Arons MM, Hatfield KM, Reddy SC, Kimball A, James A, Jacobs JR, Taylor J, Spicer K, Bardossy AC, Oakley LP, Tanwar S, Dyal JW, Harney J, Chisty Z, Bell JM, Methner M, Paul P, Carlson CM, McLaughlin H, Thornburg N, Tong S, Tamin A, Tao Y, Uehara A, Harcourt J, Clark S, Brostrom-Smith C, Page LC, Kay M, Lewis J, Montgomery P, Stone ND, Clark TA, Honein MA, Duchin JS, Jernigan JA, Public Health–Seattle and King County and CDC COVID-19 Investigation Team (2020) Presymptomatic SARS-CoV-2 infections and transmission in a skilled nursing facility. N Engl J Med 382:2081–2090
doi: 10.1056/NEJMoa2008457
Singanayagam A, Patel M, Charlett A, Lopez BJ, Saliba V, Ellis J et al (2020) Duration of infectiousness and correlation with RT-PCR cycle threshold values in cases of COVID-19, England, January to May 2020. Euro Surveill 25(32):2001483
doi: 10.2807/1560-7917.ES.2020.25.32.2001483
Wölfel R, Corman VM, Guggemos W, Seimaier M, Zange S, Müller MA et al (2020) Virological assessment of hospitalized patients with COVID-2019. Nature 581:465–469
doi: 10.1038/s41586-020-2196-x
La Scola B, Le Bideau M, Andreani J, Hoang VT, Grimaldier C, Colson P et al (2020) Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards. Eur J Clin Microbiol Infect Dis 39(6):1059–1061
doi: 10.1007/s10096-020-03913-9
Jachau K (2015) Thanatology. In: Madea B (ed) Rechtsmedizin, 3rd edn. Springer, Berlin/Heidelberg, pp 72–76
Matson M, Yinda C, Seifert SN, Bushmaker T, Fischer RJ, van Doremalen N et al (2020) Effect of environmental conditions on SARS-CoV-2 stability in human nasal mucus and sputum. Emerg Infect Dis 26(9):2276–2278
doi: 10.3201/eid2609.202267
Wang J, Du G (2020) COVID-19 may transmit through aerosol. Ir J Med Sci 189(4):1143–1144
doi: 10.1007/s11845-020-02218-2
Hanley B, Lucas SB, Youd E, Swift B, Osborn M (2020) Autopsy in suspected COVID-19 cases. J Clin Pathol 73(5):239–242
doi: 10.1136/jclinpath-2020-206522

Auteurs

Stefanie Plenzig (S)

Institute of Legal Medicine, University Hospital Frankfurt, Goethe University, Kennedyallee 104, 60596, Frankfurt am Main, Germany. plenzig@med.uni-frankfurt.de.

D Bojkova (D)

Institute of Medical Virology, University Hospital Frankfurt, Goethe University, Paul-Ehrlich-Straße 40, 60596, Frankfurt am Main, Germany.

H Held (H)

Institute of Legal Medicine, University Hospital Frankfurt, Goethe University, Kennedyallee 104, 60596, Frankfurt am Main, Germany.

A Berger (A)

Institute of Medical Virology, University Hospital Frankfurt, Goethe University, Paul-Ehrlich-Straße 40, 60596, Frankfurt am Main, Germany.

F Holz (F)

Institute of Legal Medicine, University Hospital Frankfurt, Goethe University, Kennedyallee 104, 60596, Frankfurt am Main, Germany.

J Cinatl (J)

Institute of Medical Virology, University Hospital Frankfurt, Goethe University, Paul-Ehrlich-Straße 40, 60596, Frankfurt am Main, Germany.

E Gradhand (E)

Senckenberg Institute of Pathology, University Hospital Frankfurt, Goethe University, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Germany.

M Kettner (M)

Institute of Legal Medicine, University Hospital Frankfurt, Goethe University, Kennedyallee 104, 60596, Frankfurt am Main, Germany.

A Pfeiffer (A)

Institute of Medical Virology, University Hospital Frankfurt, Goethe University, Paul-Ehrlich-Straße 40, 60596, Frankfurt am Main, Germany.

M A Verhoff (MA)

Institute of Legal Medicine, University Hospital Frankfurt, Goethe University, Kennedyallee 104, 60596, Frankfurt am Main, Germany.

S Ciesek (S)

Institute of Medical Virology, University Hospital Frankfurt, Goethe University, Paul-Ehrlich-Straße 40, 60596, Frankfurt am Main, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH